 |
인쇄하기
취소
|
Hanall Pharm stock benefits from anti-atopic medication patent
Shares of Hanall Pharm extended gains on expectations that its patent application of a novel anti-atopic drug will bring much profits in the long tem, analysts said on September 4.
Hanall closed 14.92 percent up at 18,350 won on September 4.
The company said it has filed a patent related to adenosylcobalamine, coenzyme B12, in a joint collaboration with the Korea Research Institute of Che...
Hanall closed 14.92 percent up at 18,350 won on September 4.
The company said it has filed a patent related to adenosylcobalamine, coenzyme B12, in a joint collaboration with the Korea Research Institute of Che...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.